Jolanta Airey
Net worth: - $ as of 31/07/2026
Net worth: - $ as of 31/07/2026
Dr. Jolanta Airey was previously employed as a Chief Medical Officer by Cynata Therapeutics Ltd., a Director-Translational Development by CSL Ltd., and a Head-Clinical Development Physician by CSL Seqirus Inc. She received her doctorate degree from Vilnius University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/06/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| ACRUX LIMITED | Chief Tech/Sci/R&D Officer | 24/08/2026 |
| Companies | Position | End |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | 01/01/2026 |
| CSL LIMITED | Corporate Officer/Principal | 01/10/2021 |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Acrux Ltd.
Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Vilnius University
Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions